Friday 6 November 2026
Export BRKR’s income statement to Excel — free account
Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
61.20
3.14
+5.41%
Follow BRKR
Alert me
Bruker Corporation (BRKR) P/E ratio
Bruker Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 84.5× (July 2025) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 77.1× | 211.51% |
| FY2023 | 24.8× | (28.30%) |
| FY2022 | 34.5× | (24.68%) |
| FY2021 | 45.9× | (12.75%) |
| FY2020 | 52.6× | 31.98% |
| FY2019 | 39.8× | 53.82% |
| FY2018 | 25.9× | (62.50%) |
| FY2017 | 69.0× | 203.93% |
| FY2016 | 22.7× | (42.91%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 84.5×
Ten-year median
36.0×
Current reading's percentile
9
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BRKR Bruker Corporation | n/m |
| GKOS Glaukos Corporation compare | n/m |
| TXG 10x Genomics compare | n/m |
| BIO Bio-Rad Laboratories, Inc. compare | 9.7× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 9.9× |
| GMED Globus Medical, Inc. compare | 19.5× |
| PODD Insulet Corporation compare | 25.2× |
| SNN Smith & Nephew SNATS, Inc. compare | 38.9× |
| PEN Penumbra, Inc. compare | 80.3× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement